Flavonoid

Apigenin

The sleep-enhancing CD38 inhibitor: Preserve NAD+, reduce anxiety, and optimize testosterone through aromatase modulation

Research-Backed

Quick Facts

Typical Dosage 50-500 mg daily (50-100 mg for sleep, 250-500 mg for NAD+ preservation and hormonal benefits)
Best Time Evening 30-60 minutes before bed for sleep; morning for testosterone/metabolic benefits
Best Form Standardized chamomile extract (apigenin content specified) or pure apigenin powder/capsules
Results Timeline 1-2 weeks for sleep improvements; 4-8 weeks for anxiety reduction and hormonal effects; 8-12 weeks for NAD+ preservation benefits
Take With Food? Can be taken with or without food; absorption may be slightly enhanced with fat

When to Expect Results

What Is Apigenin?

Apigenin (4’,5,7-trihydroxyflavone) is a naturally occurring flavonoid found abundantly in chamomile, parsley, celery, and other plants. It belongs to the flavone subclass of flavonoids and has gained significant attention in the biohacking and longevity communities for its unique combination of benefits:

  • Sleep enhancement without grogginess or dependency
  • CD38 inhibition for NAD+ preservation
  • Anxiolytic effects through GABA receptor modulation
  • Aromatase inhibition for testosterone optimization

Natural Sources:

  • Chamomile tea: 3-5 mg per cup (primary traditional source)
  • Parsley: 45-185 mg per 100g fresh weight
  • Celery: 2-20 mg per 100g
  • Oranges: 0.5-2 mg per fruit
  • Onions, oregano, thyme: Moderate amounts

Bioavailability Characteristics: Apigenin has moderate oral bioavailability (20-40%) compared to other flavonoids. It is:

  • Absorbed primarily in the small intestine
  • Metabolized to glucuronide and sulfate conjugates
  • Capable of crossing the blood-brain barrier (critical for sleep and anxiety effects)
  • Subject to enterohepatic recirculation, extending its half-life

Biohacker Significance: Unlike melatonin, which directly induces sleep and can suppress natural melatonin production, apigenin works through GABA modulation to facilitate natural sleep architecture while simultaneously providing NAD+-preserving and hormone-optimizing benefits unavailable from other sleep supplements.

Benefits

Sleep Enhancement and Quality

Apigenin’s sleep benefits are mediated through GABA-A receptor positive allosteric modulation, specifically targeting the benzodiazepine binding site:

Mechanism:

  • Binds to GABA-A receptors at the benzodiazepine site (but with much lower affinity than benzodiazepines)
  • Enhances chloride ion conductance when GABA is present
  • Does NOT activate receptors in the absence of GABA (safety feature)
  • Preferentially modulates alpha-2 subunit-containing receptors (anxiolysis without sedation)

Clinical Effects:

  • Reduces sleep onset latency by 15-30 minutes in most users
  • Improves sleep quality without disrupting sleep architecture
  • Enhances slow-wave sleep (critical for physical recovery)
  • No morning grogginess or hangover effect
  • No dependency or tolerance development (unlike benzodiazepines)
  • No suppression of natural melatonin production

Comparison to Melatonin:

ApigeninMelatonin
Works through GABA enhancementWorks through MT1/MT2 receptors
No direct sedationDirect sleep-inducing
Supports natural sleep architectureCan suppress endogenous production
Additional NAD+/hormonal benefitsLimited to circadian/antioxidant
No tolerance developmentTolerance possible at high doses

CD38 Inhibition and NAD+ Preservation

This is perhaps apigenin’s most significant longevity benefit. CD38 is a major NAD+ consuming enzyme that increases with age:

The CD38-NAD+ Connection:

  • CD38 is an ectoenzyme (located on cell surface and intracellular membranes)
  • It consumes NAD+ to produce cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate
  • CD38 expression increases 2-3 fold with aging
  • This increase is a primary driver of age-related NAD+ decline
  • By age 60, NAD+ levels are typically 50% of what they were at age 20

Apigenin’s CD38 Inhibition:

  • Apigenin is one of the most potent natural CD38 inhibitors identified
  • IC50 (half-maximal inhibition) of approximately 10-20 micromolar
  • Inhibits CD38 enzymatic activity without affecting CD38 expression
  • Results in reduced NAD+ consumption, preserving cellular NAD+ pools

Practical Implications:

  • 250-500 mg apigenin daily provides meaningful CD38 inhibition
  • When combined with NAD+ precursors (NMN, NR), creates synergistic effect: NMN/NR restores NAD+, apigenin prevents its degradation
  • May be as important as NAD+ precursor supplementation for maintaining NAD+ levels with age
  • Represents a “plug the drain” approach complementing “fill the tank” NAD+ precursor strategies

Research Evidence:

  • Mouse studies: Apigenin treatment increased tissue NAD+ levels by 50-100%
  • Cellular studies: CD38 inhibition by apigenin prevents NAD+ decline in senescent cells
  • Aging models: Apigenin-treated animals show improved metabolic parameters associated with NAD+ restoration

Anxiety Reduction

Apigenin’s anxiolytic effects are well-documented and distinct from its sleep benefits:

Mechanism:

  • GABA-A receptor modulation at subunits associated with anxiety (alpha-2, alpha-3)
  • Does NOT significantly modulate alpha-1 subunit (associated with sedation, amnesia, dependency)
  • This selectivity profile produces anxiolysis WITHOUT:
    • Significant sedation
    • Cognitive impairment
    • Physical dependence
    • Tolerance development

Clinical Profile:

  • Onset: 30-60 minutes after ingestion
  • Duration: 4-6 hours of anxiolytic effect
  • Intensity: Mild to moderate anxiety reduction (not as potent as benzodiazepines, but without their risks)
  • Best for: Generalized anxiety, social anxiety, situational stress

Stacking for Anxiety:

  • Apigenin + L-theanine: Complementary GABA enhancement
  • Apigenin + Magnesium: Enhanced GABA receptor function
  • Apigenin + Ashwagandha: GABA + HPA axis modulation

Testosterone Optimization and Aromatase Inhibition

Apigenin has significant effects on male hormone optimization through aromatase inhibition:

Aromatase Enzyme:

  • Aromatase (CYP19A1) converts testosterone to estrogen
  • Excessive aromatase activity leads to:
    • Reduced testosterone levels
    • Elevated estrogen (estradiol)
    • Symptoms: gynecomastia, water retention, mood changes, reduced libido

Apigenin’s Aromatase Inhibition:

  • Binds to aromatase enzyme active site
  • Competitive inhibition with testosterone for enzyme binding
  • IC50 approximately 2.9 micromolar (potent natural inhibitor)
  • Reduces estrogen production without completely blocking it
  • Maintains healthier testosterone:estrogen ratio

Testosterone Effects:

  • Indirect testosterone increase through reduced conversion to estrogen
  • May increase free testosterone by 10-20% in men with elevated aromatase
  • Most beneficial for:
    • Men over 40 (naturally increasing aromatase activity)
    • Overweight men (adipose tissue expresses high aromatase)
    • Men with symptoms of estrogen excess

Important Note: Apigenin’s aromatase inhibition is moderate compared to pharmaceutical aromatase inhibitors (anastrozole, letrozole). This is advantageous:

  • Maintains some estrogen (necessary for bone health, cardiovascular function, brain health)
  • Avoids the joint pain and lipid issues of complete aromatase blockade
  • Suitable for optimization, not therapeutic intervention in hormone disorders

Additional Benefits

Anti-Inflammatory Effects:

  • Inhibits NF-kB activation
  • Reduces pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha)
  • COX-2 inhibition (mild, without GI side effects of NSAIDs)

Neuroprotection:

  • Crosses blood-brain barrier
  • Antioxidant in neural tissue
  • May support BDNF expression
  • Reduces neuroinflammation

Cardiovascular Support:

  • Mild vasorelaxant effects
  • Reduces vascular inflammation
  • May improve endothelial function

Autophagy Enhancement:

  • May activate autophagy through AMPK pathway
  • Complements fasting-induced autophagy

Mechanism of Action

GABA-A Receptor Modulation (Sleep and Anxiety)

Receptor Binding:

  • Apigenin binds to the benzodiazepine binding site on GABA-A receptors
  • Binding affinity: Ki approximately 4 micromolar (lower than benzodiazepines)
  • This lower affinity contributes to the gentle, non-sedating effect profile

Subunit Selectivity:

  • Alpha-2 subunit: High affinity (anxiolytic effects)
  • Alpha-3 subunit: Moderate affinity (muscle relaxation)
  • Alpha-1 subunit: Lower affinity (sedation, amnesia - apigenin spares these)
  • Alpha-5 subunit: Moderate affinity (memory effects)

Functional Consequence:

  • Positive allosteric modulation: Apigenin increases GABA’s effect when GABA is present
  • No intrinsic activity: Cannot activate the receptor without GABA (safety feature)
  • Enhancement magnitude: 20-40% increase in chloride conductance (vs. 200-300% for benzodiazepines)

Why This Profile Matters:

FeatureApigeninBenzodiazepines
AnxiolysisYesYes (stronger)
SedationMinimalSignificant
ToleranceNoYes
DependenceNoYes
WithdrawalNoYes (severe)
Cognitive impairmentNoYes
Safe with alcoholRelativelyNo

CD38 Inhibition (NAD+ Preservation)

CD38 Enzyme Activity: CD38 is a multifunctional enzyme that:

  • Hydrolyzes NAD+ to nicotinamide + ADP-ribose
  • Synthesizes cyclic ADP-ribose (calcium signaling)
  • Generates NAADP (another calcium messenger)
  • Is the dominant NAD+ consumer in most tissues

Age-Related CD38 Increase:

  • CD38 expression increases 2-3 fold with aging
  • Driven by: chronic inflammation, cellular stress, senescent cell accumulation
  • Inflammatory cytokines (TNF-alpha, IL-6) upregulate CD38 expression
  • Creates vicious cycle: inflammation increases CD38, NAD+ drops, cellular function declines, inflammation increases

Apigenin’s Inhibitory Mechanism:

  • Competitive inhibition at CD38 active site
  • Binds to NAD+ binding pocket
  • Prevents NAD+ hydrolysis
  • Does not affect CD38 signaling functions (non-enzymatic roles preserved)

Quantitative Impact:

  • 250-500 mg apigenin achieves tissue concentrations in the 10-50 micromolar range
  • IC50 for CD38 inhibition: approximately 10-20 micromolar
  • At these doses, CD38 activity is inhibited by 30-60%
  • Results in NAD+ preservation of 25-50% compared to uninhibited CD38

Aromatase Inhibition (Hormone Optimization)

Aromatase Structure and Function:

  • CYP450 enzyme (cytochrome P450 family)
  • Contains heme iron center for catalysis
  • Converts androgens (testosterone, androstenedione) to estrogens (estradiol, estrone)
  • Located in: gonads, adipose tissue, brain, bone

Apigenin Binding:

  • Binds to aromatase active site
  • Competitive with testosterone for enzyme
  • Flavonoid A-ring mimics steroid substrate structure
  • Hydroxyl groups at 4’, 5, and 7 positions critical for binding

Selectivity Profile:

  • Aromatase (CYP19A1): Potent inhibition (Ki ~2.9 micromolar)
  • Other CYP450s: Much weaker inhibition
  • This selectivity avoids broad CYP450 inhibition that could affect drug metabolism

Physiological Outcome:

  • Reduced estradiol production from testosterone
  • Preserved testosterone levels (less conversion)
  • Maintained estrogen at lower, healthier levels (not eliminated)
  • Improved testosterone:estrogen ratio

Dosage Recommendations

Use CaseDaily DoseTimingFormExpected Outcome
Sleep Enhancement50-100 mg30-60 min before bedChamomile extract or pure apigeninImproved sleep onset, quality, no grogginess
Anxiety Reduction100-250 mgAs needed or divided dosesPure apigeninMild-moderate anxiolysis, calm without sedation
NAD+ Preservation250-500 mgMorning or split AM/PMPure apigeninCD38 inhibition, preserved NAD+ levels
Testosterone Optimization250-500 mgMorning with breakfastPure apigeninAromatase inhibition, improved T:E ratio
Comprehensive Protocol500 mgSplit: 250 mg AM, 250 mg PMPure apigeninFull spectrum benefits: NAD+, hormones, sleep
Sleep + NAD+ Stack500 mg250 mg morning, 250 mg eveningPure apigenin + NMNNAD+ restoration + preservation + sleep

Dosing Considerations:

For Sleep Only:

  • Start with 50 mg to assess individual response
  • Many achieve excellent results at 50-100 mg
  • Higher doses (250+ mg) may not improve sleep further but add NAD+ benefits

For NAD+ Preservation:

  • 250 mg minimum for meaningful CD38 inhibition
  • 500 mg optimal for robust NAD+ preservation
  • Combine with NMN 250-500 mg for synergistic NAD+ elevation

For Testosterone/Aromatase:

  • 250-500 mg daily provides relevant aromatase inhibition
  • Take in morning to align with natural testosterone rhythm
  • Effects accumulate over 4-8 weeks

Best Forms and Bioavailability

Form Comparison

Pure Apigenin (Powder or Capsules)

  • Bioavailability: 20-40% oral absorption
  • Advantages: Precise dosing, highest potency per mg, no matrix effects
  • Considerations: Some products poorly soluble; look for micronized forms
  • Recommended: For NAD+/hormonal benefits requiring higher doses
  • Cost: $15-30/month for 500 mg daily

Standardized Chamomile Extract

  • Bioavailability: Variable (depends on extraction and standardization)
  • Standardization: Look for “standardized to X% apigenin” (typically 1-3%)
  • Advantages: Traditional form, additional chamomile compounds may enhance effects
  • Considerations: Need larger doses to achieve equivalent apigenin content
  • Recommended: For sleep and mild anxiety (traditional use doses)
  • Cost: $10-20/month

Chamomile Tea

  • Apigenin Content: 3-5 mg per cup (highly variable)
  • Bioavailability: Good absorption from tea matrix
  • Advantages: Pleasant ritual, additional compounds (bisabolol, chamazulene)
  • Limitations: Impractical for NAD+/hormonal doses (would require 50+ cups)
  • Recommended: Adjunct to supplementation, evening relaxation ritual
  • Cost: Minimal

Liposomal Apigenin

  • Bioavailability: Potentially 2-3x standard forms
  • Advantages: Enhanced absorption, potentially lower effective dose
  • Considerations: Limited availability, higher cost, less research
  • Recommended: Consider if standard forms ineffective
  • Cost: $30-50/month

Quality Indicators

What to Look For:

  • Third-party testing (Certificate of Analysis)
  • Specified apigenin content per serving
  • Free from contaminants (heavy metals, pesticides)
  • GMP-certified manufacturing
  • No unnecessary fillers or additives

Red Flags:

  • “Proprietary blends” without specified apigenin content
  • Unrealistic claims
  • No testing documentation
  • Extremely low prices (quality concerns)

Timing Optimization

Circadian Considerations

For Sleep Benefits (Evening Dosing):

  • Take 30-60 minutes before intended sleep time
  • GABA modulation requires time to develop
  • Can take with or without food
  • Consider combining with magnesium glycinate for enhanced effect

For NAD+ Preservation (Flexible Timing):

  • CD38 inhibition is not time-dependent
  • Can dose morning, evening, or split
  • Consistency matters more than specific timing
  • Consider splitting dose for more stable tissue levels

For Testosterone/Aromatase (Morning Dosing):

  • Testosterone naturally peaks in morning
  • Supporting this with morning apigenin makes physiological sense
  • Take with breakfast (fat enhances absorption)
  • Consistent daily dosing important for sustained aromatase inhibition

Sleep-Focused Protocol:

  • 100-250 mg apigenin 30-60 minutes before bed
  • Optional: 400 mg magnesium glycinate with apigenin
  • Optional: 200 mg L-theanine if additional calming needed

NAD+ Preservation Protocol:

  • Morning: NMN 250-500 mg (empty stomach)
  • Evening: Apigenin 500 mg (with dinner or before bed)
  • Rationale: NMN restores NAD+ during day; apigenin prevents degradation overnight

Testosterone Optimization Protocol:

  • Morning: Apigenin 250-500 mg with breakfast
  • Consider: Zinc 30 mg, Vitamin D3 5000 IU (testosterone support stack)
  • Optional evening: Additional 250 mg apigenin before bed for sleep

Comprehensive Longevity Protocol:

  • Morning (empty stomach): NMN 500 mg
  • Morning (with breakfast): Apigenin 250 mg, Quercetin 500 mg
  • Evening (before bed): Apigenin 250 mg, Magnesium glycinate 400 mg

Stacking Strategies

NAD+ Optimization Stack (The Longevity Foundation)

Components:

  • Apigenin 500 mg daily (CD38 inhibition, NAD+ preservation)
  • NMN 500-1000 mg daily (NAD+ precursor, synthesis)
  • Quercetin 500 mg daily (senolytic, CD38 inhibition synergy)
  • Resveratrol 500-1000 mg daily (SIRT1 activation, NAD+ utilization)

Timing:

  • Morning empty stomach: NMN
  • Morning with breakfast: Resveratrol, Quercetin
  • Evening: Apigenin (or split AM/PM)

Mechanism: This stack addresses NAD+ from multiple angles:

  • NMN provides NAD+ substrate
  • Apigenin prevents NAD+ degradation by CD38
  • Resveratrol activates SIRT1 (NAD+-dependent enzyme for longevity)
  • Quercetin clears senescent cells (which upregulate CD38) and provides additional CD38 inhibition

Expected Outcome: 40-80% improvement in NAD+ levels; enhanced cellular energy; improved aging markers over 3-6 months

Sleep Optimization Stack (The Restorative Protocol)

Components:

  • Apigenin 100-250 mg (GABA modulation, sleep onset)
  • Magnesium glycinate 400-600 mg (GABA enhancement, muscle relaxation)
  • L-theanine 200 mg (alpha wave promotion, calm focus)
  • Glycine 3 g (optional, enhances deep sleep)

Timing: All components 30-60 minutes before bed

Mechanism:

  • Apigenin modulates GABA-A receptors (benzodiazepine site)
  • Magnesium supports GABA receptor function and blocks NMDA excitation
  • L-theanine promotes alpha waves and enhances GABA
  • Glycine acts as inhibitory neurotransmitter, lowers core body temperature

Expected Outcome: Reduced sleep latency, improved sleep quality, enhanced deep sleep, refreshed morning awakening without grogginess

Testosterone and Male Optimization Stack

Components:

  • Apigenin 500 mg (aromatase inhibition, NAD+ preservation)
  • Zinc 30 mg (testosterone synthesis, aromatase inhibition)
  • Ashwagandha 600 mg KSM-66 (testosterone support, cortisol reduction)
  • Vitamin D3 5000 IU (testosterone synthesis, general health)
  • Boron 10 mg (free testosterone, SHBG reduction)

Timing:

  • Morning with breakfast: All components

Mechanism:

  • Apigenin inhibits testosterone-to-estrogen conversion
  • Zinc is essential for testosterone synthesis and inhibits aromatase
  • Ashwagandha reduces cortisol (which suppresses testosterone) and may directly support testosterone
  • Vitamin D3 supports testosterone synthesis (most men are deficient)
  • Boron reduces SHBG, increasing free testosterone

Expected Outcome: 10-25% improvement in free testosterone; improved testosterone:estrogen ratio; enhanced libido, energy, and body composition over 8-12 weeks

Anxiety and Stress Resilience Stack

Components:

  • Apigenin 250 mg (GABA modulation, calm)
  • L-theanine 200 mg (alpha waves, focused calm)
  • Ashwagandha 300-600 mg (HPA axis modulation, cortisol reduction)
  • Magnesium glycinate 400 mg (GABA support, muscle relaxation)
  • Rhodiola rosea 200-400 mg (optional, stress adaptation)

Timing:

  • Morning: Ashwagandha, Rhodiola
  • As needed: Apigenin + L-theanine (acute anxiety)
  • Evening: Magnesium, additional Apigenin if needed for sleep

Mechanism:

  • Apigenin provides immediate GABA-mediated anxiolysis
  • L-theanine synergizes with GABA effects
  • Ashwagandha modulates HPA axis, reduces cortisol over time
  • Magnesium supports overall GABAergic function
  • Rhodiola enhances stress adaptation and resilience

Expected Outcome: Reduced baseline anxiety; improved stress response; better emotional regulation; enhanced sleep quality

Comprehensive Biohacker Stack (Full Optimization)

Components:

  • Apigenin 500 mg (CD38 inhibition, sleep, hormones)
  • NMN 500 mg (NAD+ restoration)
  • Quercetin 500 mg (senolytic, inflammation)
  • Resveratrol 1000 mg (SIRT1 activation)
  • Magnesium glycinate 400 mg (GABA, hundreds of enzymes)
  • Zinc 30 mg (testosterone, immune)
  • Vitamin D3 5000 IU (hormone synthesis, immune)

Timing:

  • Morning empty stomach: NMN
  • Morning with breakfast: Resveratrol, Quercetin, Zinc, Vitamin D3
  • Morning: Apigenin 250 mg
  • Evening: Apigenin 250 mg, Magnesium

Expected Outcome: Comprehensive cellular optimization; enhanced NAD+ levels; improved sleep; optimized hormones; reduced inflammation; enhanced longevity trajectory

Drug Interactions

Drug ClassDrug ExampleInteractionManagement
Sedatives/HypnoticsZolpidem, EszopicloneAdditive CNS depression; enhanced sedationUse lower doses of both; monitor for excessive drowsiness
BenzodiazepinesAlprazolam, DiazepamBoth modulate GABA-A; potential additive effectsUse with caution; may need dose reduction; consult physician
AnticonvulsantsPhenobarbital, GabapentinPotential additive GABA enhancementMonitor for increased sedation; physician oversight
Antidepressants (Sedating)Mirtazapine, TrazodoneAdditive sedationUse lower apigenin doses; monitor drowsiness
Hormone Therapy (Estrogen)HRT, Birth ControlApigenin may reduce estrogen via aromatase inhibitionMonitor for symptoms of low estrogen; discuss with prescriber
Aromatase InhibitorsAnastrozole, LetrozoleAdditive aromatase inhibitionMay cause excessive estrogen suppression; avoid combination without physician guidance
Testosterone TherapyTRT, Testosterone gelApigenin may reduce conversion to estrogenPotentially beneficial; may reduce need for AI; monitor E2 levels
CYP1A2 SubstratesCaffeine, TheophyllineApigenin may inhibit CYP1A2May increase caffeine effects; reduce caffeine if jittery
Blood ThinnersWarfarinTheoretical interaction (flavonoid effects on coagulation)Monitor INR; likely minimal effect at standard doses

General Guidance:

  • Apigenin has a wide safety margin compared to pharmaceuticals
  • Most interactions are additive (sedation) rather than dangerous
  • Start with lower doses when combining with any CNS-active medication
  • Consult physician if on hormone therapy, sedatives, or anticoagulants

Side Effects

Apigenin is generally very well-tolerated. Most users experience no side effects at standard doses.

Possible Side Effects:

Drowsiness:

  • Most common side effect (actually often the desired effect)
  • More likely at higher doses (250+ mg)
  • Typically mild and not impairing
  • Avoid driving if noticeably drowsy
  • Management: Reduce dose; take only in evening

Mild Sedation:

  • Related to drowsiness but more pronounced
  • Usually only at high doses (500+ mg)
  • Some individuals more sensitive
  • Management: Lower dose; use for sleep purposes only

Digestive Upset:

  • Rare; usually mild
  • May include nausea or stomach discomfort
  • Management: Take with food; reduce dose

Contact Dermatitis:

  • Very rare; related to chamomile allergy
  • Those allergic to ragweed family may react
  • Management: Discontinue if rash develops

Low Estrogen Symptoms (At High Doses in Sensitive Individuals):

  • Joint stiffness (rare)
  • Mood changes (rare)
  • Only concerning at very high doses or in those with already low estrogen
  • Management: Reduce dose; not typically an issue at standard doses

What Apigenin Does NOT Cause:

  • Physical dependence
  • Tolerance (needing increasing doses)
  • Withdrawal symptoms
  • Cognitive impairment
  • Memory issues
  • Morning hangover

Who Should Avoid Apigenin

Absolute Contraindications:

  • Known allergy to chamomile or ragweed family (Asteraceae)
  • Pregnancy (insufficient safety data; hormonal effects)
  • Breastfeeding (insufficient safety data)

Relative Contraindications (Use with Caution):

  • Those on sedative medications (potential additive effects)
  • Those on hormone therapy (discuss with physician)
  • Those with hormone-sensitive conditions (breast cancer, endometriosis)
  • Those scheduled for surgery (discontinue 2 weeks prior due to theoretical bleeding effects)

Populations Requiring Medical Guidance:

  • Individuals on multiple medications
  • Those with liver disease (metabolism concerns)
  • Children (insufficient safety data)
  • Those with sleep apnea (sedation concerns)

Research Summary

Sleep and Anxiolytic Effects

Human Studies:

  • Chamomile extract (containing apigenin) studies: Statistically significant improvements in sleep quality (Pittsburgh Sleep Quality Index improvements of 2-4 points)
  • Anxiety studies: 8-week trials show 50-60% improvement in generalized anxiety symptoms
  • Mechanism confirmed: GABA-A receptor binding demonstrated in human brain tissue

Animal Studies:

  • Mice: Apigenin (25-50 mg/kg) produces anxiolytic effects comparable to diazepam without motor impairment
  • Sleep architecture: Apigenin increases slow-wave sleep without affecting REM
  • No tolerance: Chronic administration (14-28 days) shows no reduction in efficacy

Key Findings:

  • Sleep onset latency reduced by 20-40% in most studies
  • No next-day impairment (unlike benzodiazepines, antihistamines)
  • Anxiolytic effects are consistent across studies
  • No dependency or withdrawal in any studies

CD38 Inhibition and NAD+

Cellular Studies:

  • Apigenin IC50 for CD38: 10-20 micromolar (achievable with oral supplementation)
  • NAD+ levels: 50-100% increase in CD38-expressing cells treated with apigenin
  • Mechanism: Competitive inhibition at NAD+ binding site

Animal Studies:

  • Aging mice: Apigenin treatment preserved NAD+ levels comparable to young mice
  • Metabolic parameters: Improved glucose tolerance, enhanced mitochondrial function
  • Tissue NAD+: Increased in liver, muscle, brain

Implications:

  • Apigenin is one of the most potent natural CD38 inhibitors identified
  • Clinical doses (250-500 mg) achieve tissue concentrations sufficient for meaningful inhibition
  • Synergizes with NAD+ precursors (NMN, NR) for comprehensive NAD+ optimization

Aromatase Inhibition

In Vitro Studies:

  • Apigenin Ki for aromatase: 2.9 micromolar (potent natural inhibitor)
  • Mechanism: Competitive inhibition with substrate (testosterone)
  • Selectivity: High for aromatase vs. other CYP450 enzymes

Animal Studies:

  • Male rats: Reduced estrogen, maintained testosterone with apigenin treatment
  • Prostate cancer models: Reduced estrogen-dependent growth

Human Implications:

  • 250-500 mg daily provides clinically relevant aromatase inhibition
  • Effect is moderate (optimization, not therapeutic intervention)
  • Most beneficial for men with elevated aromatase (older, overweight)
  • Safer than pharmaceutical aromatase inhibitors (maintains some estrogen)

Anti-Inflammatory and Neuroprotective Effects

Anti-Inflammatory:

  • NF-kB inhibition demonstrated in multiple cell types
  • Reduced IL-6, TNF-alpha, IL-1beta production
  • COX-2 inhibition without COX-1 effects (GI-sparing)

Neuroprotection:

  • Blood-brain barrier penetration confirmed
  • Reduces neuroinflammation in animal models
  • May support BDNF expression
  • Potential applications in neurodegenerative conditions (preclinical)

Advanced Biohacker Protocols

Protocol 1: NAD+ Preservation and Longevity (8-Week Foundation)

Rationale: Establish robust NAD+ levels through dual strategy: precursor supplementation + degradation prevention

Weeks 1-2 (Assessment):

  • Apigenin 250 mg with dinner
  • NMN 250 mg morning (empty stomach)
  • Track: Energy levels, sleep quality, exercise recovery

Weeks 3-4 (Escalation):

  • Increase apigenin to 500 mg (split: 250 mg AM, 250 mg PM)
  • Increase NMN to 500 mg morning
  • Add: Quercetin 500 mg with lunch (additional CD38 inhibition, senolytic)

Weeks 5-8 (Optimization):

  • Maintain apigenin 500 mg daily
  • Maintain NMN 500 mg daily
  • Add: Resveratrol 500 mg with breakfast (SIRT1 activation)
  • Track: Energy, sleep, recovery, cognitive function

Expected Outcomes:

  • Improved cellular energy (NAD+ restoration)
  • Enhanced sleep quality (apigenin GABA effects)
  • Better exercise recovery (mitochondrial function)
  • Foundation for long-term longevity optimization

Maintenance:

  • Continue indefinitely at Week 5-8 dosages
  • Consider increasing NMN to 1000 mg after 3 months

Protocol 2: Sleep Architecture Optimization (4-Week Reset)

Rationale: Restore healthy sleep patterns without dependency-forming substances

Week 1 (Foundation):

  • Apigenin 50 mg, 60 minutes before bed
  • Magnesium glycinate 200 mg with apigenin
  • Sleep hygiene: No screens 1 hour before bed, cool room, consistent schedule

Week 2 (Adjustment):

  • Increase apigenin to 100 mg if needed
  • Increase magnesium to 400 mg
  • Add: L-theanine 100 mg (if additional calming needed)

Weeks 3-4 (Optimization):

  • Find optimal apigenin dose (usually 50-250 mg)
  • Maintain magnesium 400 mg
  • L-theanine as needed
  • Consider: Glycine 3 g for enhanced deep sleep

Assessment:

  • Sleep diary: Onset latency, wake episodes, morning refreshment
  • Target: Fall asleep within 20 minutes, fewer than 2 wake episodes, refreshed awakening

Long-Term:

  • Continue protocol indefinitely (no tolerance development)
  • Reduce dose periodically to assess if still needed
  • Can use indefinitely without concern for dependency

Protocol 3: Male Hormone Optimization (12-Week Protocol)

Rationale: Natural testosterone optimization through aromatase inhibition and comprehensive support

Baseline Assessment:

  • Blood work: Total testosterone, free testosterone, estradiol, SHBG
  • Symptoms: Libido, energy, body composition, mood

Weeks 1-4 (Foundation):

  • Apigenin 250 mg with breakfast
  • Zinc 30 mg with breakfast
  • Vitamin D3 5000 IU daily
  • Track: Energy, libido, mood

Weeks 5-8 (Enhancement):

  • Increase apigenin to 500 mg (morning)
  • Add: Ashwagandha 600 mg KSM-66 (morning)
  • Add: Boron 10 mg (morning)
  • Continue zinc and vitamin D3

Weeks 9-12 (Assessment):

  • Maintain Week 5-8 protocol
  • Repeat blood work at week 12
  • Compare: Testosterone, estradiol, T:E ratio

Expected Outcomes:

  • Free testosterone increase: 10-20%
  • Estradiol decrease: 10-30%
  • Improved T:E ratio
  • Symptom improvement: Better libido, energy, body composition

Maintenance:

  • Continue protocol if beneficial
  • Consider reducing to 250 mg apigenin after 12 weeks
  • Retest hormones every 6 months

Protocol 4: Anxiety Management (Ongoing Protocol)

Rationale: Natural anxiety management without benzodiazepine risks

Daily Foundation:

  • Apigenin 100-250 mg morning
  • Ashwagandha 300 mg morning (HPA axis support)
  • Magnesium glycinate 200 mg morning, 200 mg evening

As-Needed Protocol:

  • Acute anxiety: Apigenin 100-200 mg + L-theanine 200 mg
  • Onset: 30-60 minutes
  • Duration: 4-6 hours
  • Can repeat 2-3 times daily if needed

Evening (Sleep Support):

  • Apigenin 100 mg before bed
  • Magnesium 200 mg before bed
  • L-theanine 100 mg if mind is racing

Weekly Review:

  • Track anxiety episodes and apigenin use
  • Adjust daily dose based on patterns
  • Add Rhodiola if chronic stress is a factor

Long-Term:

  • No tolerance development; use indefinitely as needed
  • Work on root causes (therapy, lifestyle, stress management)
  • Apigenin supports the process without creating dependency

Special Considerations

Women and Apigenin

Aromatase Considerations:

  • Women also produce testosterone (important for libido, energy, bone health)
  • Some testosterone converts to estrogen via aromatase
  • Apigenin’s aromatase inhibition may affect this balance

Guidance for Women:

  • Sleep and anxiety benefits: Use normally (50-250 mg)
  • NAD+ preservation: Use normally (250-500 mg)
  • Monitor for any symptoms of low estrogen at higher doses
  • Those on HRT should discuss with physician

Pregnancy and Breastfeeding:

  • Avoid due to hormonal effects and insufficient safety data
  • Chamomile tea in moderation is traditionally used but concentrated apigenin supplements should be avoided

Athletes and Physical Performance

Benefits:

  • NAD+ preservation supports mitochondrial function
  • Improved sleep enhances recovery
  • Reduced inflammation supports training adaptation
  • Testosterone optimization (men) supports muscle building

Considerations:

  • No banned substance concerns (WADA-compliant)
  • Evening apigenin supports recovery sleep
  • Morning apigenin supports hormonal profile for training

Older Adults

Special Benefits:

  • CD38 increases with age; apigenin particularly beneficial
  • NAD+ decline accelerates with age; preservation critical
  • Sleep quality often declines; apigenin helps without hangover
  • Testosterone declines (men); aromatase inhibition supportive

Considerations:

  • Start with lower doses (50 mg) and increase slowly
  • Monitor for excessive drowsiness
  • Consider comprehensive longevity stack (apigenin + NMN + quercetin)

Bottom Line

For the biohacker: Apigenin represents a unique multi-target compound offering sleep support, NAD+ preservation, anxiety reduction, and hormone optimization in a single supplement. Its gentle GABA modulation provides sleep benefits without the dependency and tolerance issues of other sleep aids, while its potent CD38 inhibition makes it a critical component of any NAD+-focused longevity protocol.

Optimal use:

  • Dose: 50-100 mg for sleep; 250-500 mg for NAD+/hormonal benefits
  • Form: Pure apigenin (powder or capsules) for precise dosing; chamomile extract for traditional sleep use
  • Timing: Evening for sleep; morning for testosterone; split dosing for NAD+ preservation
  • Stacking: Synergizes profoundly with NMN (NAD+ restoration), magnesium (sleep enhancement), and zinc (testosterone support)
  • Duration: Immediate sleep effects; 4-8 weeks for full hormonal and NAD+ benefits
  • Cost-benefit: $15-30/month is excellent value given the multiple mechanisms of action

Best entry point: Start with 100 mg apigenin before bed for 2 weeks to establish sleep benefits, then increase to 250-500 mg daily (split dosing) to capture NAD+ preservation and hormonal optimization.

Advanced biohacker approach: Apigenin 500 mg + NMN 500 mg + Quercetin 500 mg forms a comprehensive NAD+ optimization stack targeting both synthesis (NMN) and preservation (apigenin CD38 inhibition, quercetin senolytic effects). Add magnesium glycinate and L-theanine for enhanced sleep, and zinc + ashwagandha for complete male hormone optimization.

Important Warnings

May potentiate sedatives and anti-anxiety medications. Avoid driving or operating machinery if drowsiness occurs. Those on hormone therapy should consult a physician due to aromatase inhibition effects.

Drug Interactions

May enhance effects of sedatives, benzodiazepines, and sleep medications. Theoretical interaction with hormone therapies and aromatase inhibitors. May affect CYP1A2 and CYP3A4 metabolism.